CARDIOMYOPATHY ASSOCIATED WITH HIGH-DOSE INTERLEUKIN-2 THERAPY

被引：0
|
作者：
BECK, AC
WARD, JH
HAMMOND, EH
WRAY, RB
SAMLOWSKI, WE
机构：
[1] UNIV UTAH,VET AFFAIRS MED CTR,DEPT INTERNAL MED,CANC IMMUNOTHERAPY PROGRAM,SALT LAKE CITY,UT 84112
[2] DEPT VET AFFAIRS MED CTR,SALT LAKE CITY,UT
[3] LATTER DAY ST HOSP,DEPT PATHOL,SALT LAKE CITY,UT 84143
[4] UNIV UTAH,SCH MED,DEPT PATHOL,SALT LAKE CITY,UT 84112
来源：
WESTERN JOURNAL OF MEDICINE | 1991年 / 155卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：293 / 296
页数：4
相关论文
共 50 条
  • [1] REVERSIBLE CARDIOMYOPATHY AFTER HIGH-DOSE INTERLEUKIN-2 THERAPY
    GOEL, M
    FLAHERTY, L
    LAVINE, S
    REDMAN, BG
    [J]. JOURNAL OF IMMUNOTHERAPY, 1992, 11 (03): : 225 - 229
  • [2] EOSINOPHILIC MYOCARDITIS ASSOCIATED WITH HIGH-DOSE INTERLEUKIN-2 THERAPY
    SCHUCHTER, LM
    HENDRICKS, CB
    HOLLAND, KH
    SHELTON, BK
    HUTCHINS, GM
    BAUGHMAN, KL
    ETTINGER, DS
    [J]. AMERICAN JOURNAL OF MEDICINE, 1990, 88 (04): : 439 - 440
  • [3] Focal Takotsubo Cardiomyopathy With High-Dose Interleukin-2 Therapy for Malignant Melanoma
    Damodaran, Senthil
    Mrozek, Ewa
    Liebner, David
    Kendra, Kari
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2014, 12 (12): : 1666 - 1670
  • [4] Management of toxicities associated with high-dose interleukin-2 and biochemotherapy
    Poust, Jamie C.
    Woolery, Joseph E.
    Green, Myke R.
    [J]. ANTI-CANCER DRUGS, 2013, 24 (01) : 1 - 13
  • [5] COLONIC PERFORATION - AN UNUSUAL COMPLICATION OF THERAPY WITH HIGH-DOSE INTERLEUKIN-2
    SCHWARTZENTRUBER, D
    LOTZE, MT
    ROSENBERG, SA
    [J]. CANCER, 1988, 62 (11) : 2350 - 2353
  • [6] EFFECT OF CALCIUM REPLACEMENT OF THE HEMODYNAMIC-CHANGES ASSOCIATED WITH HIGH-DOSE INTERLEUKIN-2 THERAPY
    REDMAN, BG
    FLAHERTY, L
    MARTINO, S
    KRAUT, M
    WISNIEWSKI, C
    VALDIVIESO, M
    BANDER, JJ
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1992, 15 (04): : 340 - 343
  • [7] COMPLEMENT ACTIVATION AND HIGH-DOSE OF INTERLEUKIN-2
    THIJS, LG
    HACK, CE
    VANSCHIJNDEL, RJMS
    NUIJENS, JH
    WOLBINK, GJ
    EERENBERGBELMER, AJM
    VANDERVALL, H
    WAGSTAFF, J
    [J]. LANCET, 1989, 2 (8659): : 395 - 395
  • [8] Managing toxicities of high-dose interleukin-2
    Schwartz, RN
    Stover, L
    Dutcher, J
    [J]. ONCOLOGY-NEW YORK, 2002, 16 (11): : 11 - 20
  • [9] High-Dose Ipilimumab and High-Dose Interleukin-2 for Patients With Advanced Melanoma
    Silk, Ann W.
    Kaufman, Howard L.
    Curti, Brendan
    Mehnert, Janice M.
    Margolin, Kim
    McDermott, David
    Clark, Joseph
    Newman, Jenna
    Bommareddy, Praveen K.
    Denzin, Lisa
    Najmi, Saltanat
    Haider, Azra
    Shih, Weichung
    Kane, Michael P.
    Zloza, Andrew
    [J]. FRONTIERS IN ONCOLOGY, 2020, 9
  • [10] High-dose interleukin-2 may not be superior to low-dose interleukin-2 plus interferon
    Alikhan, M
    Spencer, HJ
    Kohli, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) : 6267 - 6268
12345